comparemela.com

Latest Breaking News On - Silverarc capital management - Page 1 : comparemela.com

Aerovate Therapeutics (NASDAQ:AVTE) Stock Price Up 3 6%

Aerovate Therapeutics, Inc. (NASDAQ:AVTE – Get Free Report) shot up 3.6% during mid-day trading on Thursday . The company traded as high as $24.05 and last traded at $23.86. 59,742 shares traded hands during trading, a decline of 62% from the average session volume of 159,164 shares. The stock had previously closed at $23.02. Wall […]

Forefront Analytics LLC Purchases 6,765 Shares of Zura Bio Limited (NASDAQ:ZURA)

Forefront Analytics LLC grew its stake in Zura Bio Limited (NASDAQ:ZURA – Free Report) by 46.8% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 21,229 shares of the company’s stock after purchasing an additional 6,765 shares during the period. Forefront […]

Bellevue Group AG Has $95 75 Million Stock Position in MacroGenics, Inc (NASDAQ:MGNX)

Bellevue Group AG raised its stake in MacroGenics, Inc. (NASDAQ:MGNX – Free Report) by 1.5% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 9,953,313 shares of the biopharmaceutical company’s stock after acquiring an additional 150,000 shares during the quarter. MacroGenics comprises approximately […]

Platinum Investment Management Ltd Has $606,000 Stock Holdings in Sagimet Biosciences Inc (NASDAQ:SGMT)

Platinum Investment Management Ltd. lowered its position in Sagimet Biosciences Inc. (NASDAQ:SGMT – Free Report) by 70.9% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 111,752 shares of the company’s stock after selling 272,161 shares during the period. Platinum Investment Management Ltd. owned 0.52% of Sagimet Biosciences […]

AdvisorShares Investments LLC Has $309,000 Position in Relmada Therapeutics, Inc (NASDAQ:RLMD)

AdvisorShares Investments LLC cut its stake in shares of Relmada Therapeutics, Inc. (NASDAQ:RLMD – Free Report) by 33.9% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 74,666 shares of the company’s stock after selling 38,242 shares during the period. AdvisorShares Investments LLC owned 0.25% of […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.